Table 3 Autoantibodies against the antigens detected women with breast tumors as compared to control women or women with benign tumors.

From: Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients

Test variable(s)

AUC

Significance

95% Confidence interval

Lower

Upper

DCIS vs. control

0.93

p < 0.0001

0.88

0.98

DCIS vs. benign

0.73

p = 0.01

0.55

0.90

IBC vs. control

0.80

p < 0.0001

0.69

0.91

IBC vs. benign

0.99

p < 0.0001

0.96

1.0

Hyperplasia vs. control

0.52

p = 0.84

0.29

0.75

Hyperplasia vs. benign

0.69

p = 0.13

0.47

0.91

Fibrocystic vs. control

0.96

p < 0.0001

0.90

1.0

Fibrocystic vs. benign

0.68

p = 0.07

0.50

0.86

  1. DCIS ductal carcinoma in situ, IBC invasive breast cancer. Benign: radial scar, cyst, or no fibroadenoma or atypia found in women with mass detected by mammography.
Back to article page